Background
In response to the demonstration that injection in a single venue in New Delhi, India accounted for >70% of incident HIV infections in people who inject drugs (PWID) (overall incidence 21.3 per 100 person years [PY]), in October 2023, we established a person-centered facility (“Blue Shed”) in the venue through public-private partnership. The Blue Shed provides community-driven services including medical services (HIV, HCV and HBV testing, TB screening, linkage to medications, on-site abscess management and clinical care), harm reduction (counseling, medication for opioid use disorder [MOUD], syringe services) and social services (showers, toilets, haircuts and sweaters/blankets).
Methods
At the Blue Shed, all medical and social services have been available on-site since inception and are voluntary. Clients (PWID and others) drop in as needed and are not compensated for service use. Service utilization is linked to biometric data. Antibody testing for HIV, HCV, and HBsAg is offered to all at registration; those who test negative have the option to rescreen every six months. All testing is done on-site with rapid point-of-care diagnostics. Using service utilization data, we characterize the burden of HIV, HBV and HCV, and incidence of HIV and primary HCV infection.
Results
From October 2023 through August 2025, 1,276 participants visited the Blue Shed. Median age was 27 years and 98.3% were assigned male sex at birth; 88% were unemployed or daily wage earners. 87% reported injecting drugs in the prior month and ~60% had a history of sharing injection paraphernalia. Baseline HIV, HCV and HBsAg prevalence among the clients screened were 45.2% (564/1248), 74.1% (932/1259) and 7.5% (95/1259), respectively. 229 of 684 clients who screened negative/indeterminate for HIV had a repeat test; we observed 62 seroconversions over 176.8 PY of follow-up (incidence rate: 35 per 100 PY). 93 participants who were HCV negative at baseline had a repeat HCV test; 30 of them screened positive (HCV incidence: 44.2 per 100 PY).
Conclusions
Establishment of a person-centered facility in response to geospatial transmission data attracted a population with high HIV, HCV and HBV burden and elevated risk behaviors. However, despite the provision of integrated medical and social services desired by the population, incidence of HIV and HCV remains unacceptably high. Integration of novel strategies (e.g., long-acting ARVs) are needed to reduce incidence in such settings.